Related Experiment Video
Updated: Jul 17, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Migraine in the elderly: a review.
J Haan1, J Hollander, M D Ferrari
1Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands. jhaan@rijnland.nl
Cephalalgia : an International Journal of Headache
|January 30, 2007
Summary
Migraine affects fewer older adults, but rising numbers mean more elderly patients need care. This review covers migraine in those over 60, focusing on comorbidities and age-appropriate treatments.
Area of Science:
- Neurology
- Geriatrics
- Epidemiology
Background:
- Migraine prevalence decreases with age, but population growth in older demographics increases the total number of elderly migraineurs.
- This demographic shift necessitates greater medical attention for migraine in individuals aged 60 years and older.
- Understanding the unique aspects of migraine in the elderly is crucial for effective management.
Purpose of the Study:
- To review the epidemiology and clinical features of migraine in individuals aged 60 years and above.
- To highlight the importance of comorbidities in elderly migraine patients.
- To discuss age-specific treatment considerations for migraine in older adults.
Main Methods:
- Literature review focusing on studies concerning migraine in the elderly population (> or =60 years).
- Analysis of epidemiological data, clinical presentations, and associated comorbidities.
- Evaluation of current treatment strategies in the context of physiological and pathological aging.
Main Results:
- While less common, migraine in older adults presents distinct clinical characteristics.
- Comorbidities are highly prevalent and significantly impact migraine management in this age group.
- Treatment decisions must account for age-related physiological changes and potential drug interactions.
Conclusions:
- Migraine management in the elderly requires a tailored approach considering their specific epidemiological and clinical profiles.
- Comorbidity assessment and management are paramount for optimizing treatment outcomes.
- Future research should focus on evidence-based therapeutic strategies for migraine in aging populations.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...